These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14506915)

  • 1. Potential inhibitors of angiogenesis. Part I: 3-(imidazol-4(5)-ylmethylene)indolin-2-ones.
    Braud E; Duflos M; Nourrisson MR; Tonnerre A; Picot C; Le Baut G; Renard P; Pfeiffer B; Tucker G
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):243-52. PubMed ID: 14506915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential inhibitors of angiogenesis. Part II: 3-(azolylmethylene)-2,3-dihydrobenzo[b]furan-2-ones.
    Braud E; Duflos M; Le Baut G; Renard P; Pfeiffer B; Tucker G
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):253-7. PubMed ID: 14506916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and preliminary evaluation of 5,7-dimethyl-2-aryl-3H-pyrrolizin-3-ones as angiogenesis inhibitors.
    Kirk NS; Bezos A; Willis AC; Sudta P; Suksamrarn S; Parish CR; Ranson M; Kelso MJ
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1813-6. PubMed ID: 26912111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.
    Sun L; Tran N; Tang F; App H; Hirth P; McMahon G; Tang C
    J Med Chem; 1998 Jul; 41(14):2588-603. PubMed ID: 9651163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoinduced Isomerization and Hepatoxicities of Semaxanib, Sunitinib and Related 3-Substituted Indolin-2-ones.
    Ngai MH; So CL; Sullivan MB; Ho HK; Chai CL
    ChemMedChem; 2016 Jan; 11(1):72-80. PubMed ID: 26593399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors.
    Peifer C; Stoiber T; Unger E; Totzke F; Schächtele C; Marmé D; Brenk R; Klebe G; Schollmeyer D; Dannhardt G
    J Med Chem; 2006 Feb; 49(4):1271-81. PubMed ID: 16480264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of prodrugs for anti-angiogenic pyrrolylmethylidenyl oxindoles.
    Maskell L; Blanche EA; Colucci MA; Whatmore JL; Moody CJ
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1575-8. PubMed ID: 17254788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase inhibitors. 3. Structure-activity relationships for inhibition of protein tyrosine kinases by nuclear-substituted derivatives of 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide).
    Rewcastle GW; Palmer BD; Dobrusin EM; Fry DW; Kraker AJ; Denny WA
    J Med Chem; 1994 Jun; 37(13):2033-42. PubMed ID: 8027985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies of indolin-2-one derivatives as vascular endothelial growth factor receptor inhibitors and anticancer agents.
    Yousefian M; Ghodsi R
    Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000022. PubMed ID: 32885522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodinated sunitinib as a potential radiotracer for imaging angiogenesis-radiosynthesis and first radiopharmacological evaluation of 5-[125I]Iodo-sunitinib.
    Kuchar M; Oliveira MC; Gano L; Santos I; Kniess T
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2850-5. PubMed ID: 22444679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
    Laird AD; Vajkoczy P; Shawver LK; Thurnher A; Liang C; Mohammadi M; Schlessinger J; Ullrich A; Hubbard SR; Blake RA; Fong TA; Strawn LM; Sun L; Tang C; Hawtin R; Tang F; Shenoy N; Hirth KP; McMahon G; Cherrington
    Cancer Res; 2000 Aug; 60(15):4152-60. PubMed ID: 10945623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of 1-furfuryl-indolin-2-one derivatives and preliminary evaluation of their antitumor activities].
    Dong XC; Zhou FS; Zheng JB; Wen R
    Yao Xue Xue Bao; 2008 Jan; 43(1):54-9. PubMed ID: 18357732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 3-substituted-indolin-2-one derivatives containing chloropyrrole moieties.
    Jin YZ; Fu DX; Ma N; Li ZC; Liu QH; Xiao L; Zhang RH
    Molecules; 2011 Nov; 16(11):9368-85. PubMed ID: 22068619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profile.
    Chiang CC; Lin YH; Lin SF; Lai CL; Liu C; Wei WY; Yang SC; Wang RW; Teng LW; Chuang SH; Chang JM; Yuan TT; Lee YS; Chen P; Chi WK; Yang JY; Huang HJ; Liao CB; Huang JJ
    J Med Chem; 2010 Aug; 53(16):5929-41. PubMed ID: 20681538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and radiopharmacological investigation of 3-[4'-[(18)F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitor.
    Kniess T; Bergmann R; Kuchar M; Steinbach J; Wuest F
    Bioorg Med Chem; 2009 Nov; 17(22):7732-42. PubMed ID: 19822433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: structure-activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-a]pyrrolo[3,4-c]carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055.
    Gingrich DE; Reddy DR; Iqbal MA; Singh J; Aimone LD; Angeles TS; Albom M; Yang S; Ator MA; Meyer SL; Robinson C; Ruggeri BA; Dionne CA; Vaught JL; Mallamo JP; Hudkins RL
    J Med Chem; 2003 Dec; 46(25):5375-88. PubMed ID: 14640546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in silico, in vitro, and in vivo investigation of 5-[¹¹C]methoxy-substituted sunitinib, a tyrosine kinase inhibitor of VEGFR-2.
    Caballero J; Muñoz C; Alzate-Morales JH; Cunha S; Gano L; Bergmann R; Steinbach J; Kniess T
    Eur J Med Chem; 2012 Dec; 58():272-80. PubMed ID: 23131541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel 3-aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors.
    Peifer C; Selig R; Kinkel K; Ott D; Totzke F; Schächtele C; Heidenreich R; Röcken M; Schollmeyer D; Laufer S
    J Med Chem; 2008 Jul; 51(13):3814-24. PubMed ID: 18529047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.